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ABSTRACT 
Background: Recent studies on Pre-exposure prophylaxis treatment (PrEP) has received 
significant recognition as a promising preventive strategy among high risk individuals. Likewise, 
rapid growth of research on information and communication technology regarding HIV prevention 
has also demonstrated a strong influence on health behaviors. Although a significant amount of 
research has been conducted on willingness, perceived risk of PrEP use, and NCI as predictors of 
HIV risk behavior, no study to date, has explored the impact of various motivation factors along 
with the use of internet & communication technology devices and psychological aspects on PrEP 
adherence self-efficacy. So, the objectives of theses analyses were to examine whether various 
motivation factors, psychological factors, and communication technology predicts PrEP adherence 
self-efficacy. 
Method: The study was conducted among 400 HIV-negative high risk PWUD enrolled in a 
community based methadone maintenance treatment program and reporting drug and /or sex 
related HIV risk behavior in the past 6-months. Participants completed an audio-computer-assisted 
self-interview (ACASI) which measured motivation, Neurocognitive impairment (NCI), 
depression, use of internet and technology devices and adherence self-efficacy. A factor analysis 
was conducted to determine different motivation factors. In order to examine significant 
association, we conducted linear regression analyses of different factors on PrEP adherence self-
efficacy. 
Result: The analysis showed the social motivation (β=.32, p =.00) and attitudes about PrEP use 
(β=.139, p=.004) predicted PrEP adherence self-efficacy. However, intention motivation for PrEP 
X 
 
(β= -0.241, p>0.05) showed a reciprocal relationship with adherence self-efficacy. Finding 
highlights that use of internet (β=0.09, p=0.017) has a positive impact on adherence self-efficacy 
along with the use of technology devices (β=0213, p<0.05). On the other hand, psychological 
factor which involves depression (β=0.145. p=0.04) marginally predicts PrEP adherence self- 
efficacy, but NCI was not associated with PrEP adherence self-efficacy. 
Conclusion: The, results suggest that the accessibility of internet use among high risk drug users 
along with motivation for PrEP use can significantly contribute to PrEP adherence. The significant 
association with motivation and use of technology benefits strengthens our knowledge about 
important factors affecting PrEP use among high risk individuals that may be valuable to 
incorporate into future interventions.  
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CHAPTER 1:  INTRODUCTION 
HIV continues to be a significant global health issue and a matter of concern among high 
risk drug users. Although the number of new HIV infections has declined by over 30% in the past 
decade, the number of people who contract  new HIV infection each year is still unacceptably high 
(World health organization, 2016);(CDC, 2015b). People who uses drugs (PWUD) continue to 
account for HIV transmission related to the injection drug use. (“HIV Survillance Report, CDC,” 
2016) (World health organization, 2016) Despite HIV transmission being fueled through injection 
drug use, there remains inadequate attention and resources devoted to evidence based HIV 
prevention among high risk population. (Marshall & Wood, 2010);(UNAIDS, 2014);(“Opioids | 
National Institute on Drug Abuse (NIDA),” 2016). Furthermore, understanding the various 
important aspects of HIV transmission dynamics is an essential component in order to facilitate 
the containment of its epidemic.(UNAIDS, 2016)(Marshall & Wood, 2010) . 
Reports on the global AIDS epidemic confirms that the decline in new HIV infections over 
the past 10 years is clearly linked with changes in behavior and social norms together with 
increased knowledge of HIV (UNAIDS, 2016);(World health organization, 2016). Due to 
prevailing barriers for HIV prevention strategies, it has now become a public health challenge.  
In the current period, the concept of health, behavior and the continuum of care among the 
various vulnerable groups are directly shaped by the communication and health information 
technology (Hightow-Weidman, Muessig, Bauermeister, Zhang, & LeGrand, 2015)(Beck et al., 
2014). In the core context to health care, the perspective of high risk population, ways for public 
search and use of health information significantly impact their behaviors and decisions. In addition, 
health literacy and motivation are the factors that may contribute to the willingness to adhere to 
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HIV prevention and treatment among the various high-risk populations. However, inequalities in 
internet access for the health related knowledge and motivation may be a limiting factor in that 
this is linked with the health disparities and awareness regarding the HIV prevention. (S. C. 
Kalichman et al., 2006);(Erik P. Bucy, 2008)(Hightow-Weidman et al., 2015).  
Among the promising intervention for HIV prevention Pre-exposure prophylaxis (PrEP) is 
one of the preventive strategies for use before potential exposure to the HIV virus. The rising 
recognition of pre-exposure prophylaxis treatment has made a significant impact as a biomedical 
preventive strategy for HIV transmission. However, there is concern about the risk perception or 
sexual risk behavior and corresponding stereotypes of promiscuity and that the use of PrEP may 
undermine its preventive potential.  
In terms of determining the underlying potential benefits of PrEP to high risk populations, 
the World Health Organization (WHO) has recommended that PrEP should be offered as a choice 
to people who are at substantial risk of HIV infection. New insights into the infection mechanism 
and the importance of the route of transmission may eventually lead to future preventive efforts. 
(UNAIDS, 2014). Breakthroughs in HIV prevention are  important to the public including a variety 
of intervention  such as antiretroviral therapy to the people living with HIV and PrEP for high risk 
HIV negative individuals.(Pre-exposure prohylaxis practice, 2014). Antiretroviral treatment 
(ART) medications markedly increase the survival of HIV infected persons and have long been 
the cornerstone of strategies to prevent vertical HIV transmission. PrEP is an HIV prevention 
strategy that involves the daily use of ART by HIV-negative persons to prevent infection and also 
have the potential for the wide range impact to overcome HIV acquisition. 
 Although studies have been conducted on the efficacy of PrEP and individual’s adherence 
to it, to date there is limited evidence of motivation-related factors and adherence self-efficacy 
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(Liu et al., 2016);(Brooks et al., 2011). Available studies and reports support the efficacy of pre-
exposure prophylaxis treatment in reducing the incidence of HIV infection as a new biomedical 
primary prevention approach among high risk HIV populations However there is lack of data 
examining the possible role of internet use , information and technology to enhance  motivation 
for PrEP adherence self-efficacy as an innovative and effective preventive approach for HIV 
(Laugesen, Hassanein, & Yuan, 2015). The health resources available through the use of internet 
and communication technology could improve behavior modification potential and boost 
participants’ confidence in adhering to the appropriate treatment and intervention process to 
manage various health problem. (Curioso et al., 2007); (Jayakumaran, Aaron, Gracely, Schriver, 
& Szep, 2016). 
The IMB theoretical model (Fisher, Fisher, & Harman, 2003) that is directly relevant to 
the performance of health behavior asserts that health-related information, personal or social 
motivation and behavioral skills are the critical determinants of health behavior performance. 
Based on the IMB model, understanding the adherence self-efficacy related to PrEP may be a key 
to identifying the potential predictors within the IMB constructs among this high-risk population 
(Sun Ju Chang, 2014). Similarly, prior studies based on the IMB model framework (Shrestha, 
Altice, Huedo-Medina, Karki, & Copenhaver, 2017) have shown significant associations in terms 
of willingness to use PrEP and IMB constructs. Another study also supports the potential 
adaptation of the IMB model for treatment adherence among a younger population (Rongkavilit 
et al., 2010). The study also suggests that consideration should be given to broadening the 
motivation construct to include other relational factors. While the IMB model have been utilized 
as a theoretical framework in examining a wide range of health behavior changes, it is yet to 
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explore the different forms of information and motivation constructs and examine the potential 
impact in terms of PrEP use and its adherence self-efficacy.  
Evidence from prior studies and systematic reviews has shown the reciprocal relationship 
on neurocognitive impairment on medication adherence (Anand, Springer, Copenhaver, & Altice, 
2010). In contrast study results demonstrates that participants with higher neurocognitive 
impairment and drug users have shown poor medication adherence and self- efficacy (Arentsen et 
al., 2016). Despite the success of ART in HIV prevention and treatment, NCI and other factors 
related to cognitive impairment has highly affected medication adherence and risk behaviors 
(Pinheiro et al., 2016).Therefore, it is also important to look at the relationship between different 
cognitive factors and PrEP adherence self- efficacy which would be a contribution in developing 
potential effective intervention for mediation adherence. 
Specific Aims and objectives 
The aim of this study is to identify and investigate the factors influencing PrEP adherence 
self-efficacy among a sample of high risk drug users. Underlying the assessment and finding in 
prior studies in high risk populations this has become as a crucial priority. The objectives of this 
thesis are to investigate different aspects of motivation and attitude for the use of PrEP affecting 
the adherence self-efficacy (Chariyalertsak et al., 2011);(Brooks et al., 2011); (Turan, Fazeli, 
Raper, Mugavero, & Johnson, 2016). Secondary objectives of this study are to determine the 
potential role of internet, communication and technology alongside to identify the influence of 
NCI and depression as psychological factors on PrEP adherence self- efficacy. (Laugesen et al., 
2015)(Meade, Conn, Skalski, & Safren, 2011). 
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CHAPTER 2: REVIEW OF LITERATURE 
 
2.1 Global Epidemiology of HIV/AIDS 
 
Along with the tuberculosis and Malaria, HIV is still one of the leading cause of death 
worldwide.(“WHO | Data and statistics,” 2016)(Fettig, Swaminathan, Murrill, & Kaplan, 
2014).The HIV/AIDS epidemics has not left untouched any corner of the world and continues to 
exceeds the pessimistic projections made years ago. The human immune deficiency virus was 
believed to have originated from the historic trade routes of Congo basin in the 1920s. Researchers 
discovered that chimpanzee were the source of the HIV-1 virus and over the course of time it was 
found that those viruses have crossed species to humans (Worobey et al., 2010). The global HIV 
burden has claimed, approximately 36.7 million people worldwide living with HIV/AIDS as of 
the end of 2015 (World health organization, 2016). An estimated 2.1 million individuals 
worldwide became newly infected with HIV in 2015 and 60% of those people living with HIV 
know their status whereas remaining 40% are still unaware of their status(CDC, 2015a).  
The prevalence of HIV is increasing in some geographical regions which is attributed to 
death averted from the antiretroviral treatment (Fettig et al., 2014);(UNAIDS, 2014). Unlike the 
HIV epidemics in the Asian and sub Saharan African countries, new infections and HIV related 
mortality has been steadily accelerating in the North Africa and Middle Eastern region. HIV/AIDS 
related deaths in sub Saharan Africa fell from 2005 to 2013 by 39% but with a very high original 
base rate, the region still accounted for 74% of the total HIV/AIDS related deaths. In comparison, 
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modest declines occurred (~ 27%) in Asia and the Pacific regions. In the Caribbean, it declined by 
54%, in Latin America by 31% and by 19% in Oceania with lowest mortality rate of 2% in central 
Europe and North America. (Fettig et al., 2014); (UNAIDS, 2014)(GAP). Analyzing HIV 
diagnosis into various categories, the various reports presented in 2015, and the African American 
population appears to be most affected by HIV, with 45% of all new diagnosis. Similarly, 
Hispanics and Latinos populations are also strongly affected accounting for 24% of all HIV 
diagnoses (CDC, 2015a).  
The worldwide response to HIV largely neglects young populations, which includes people 
trading sex, men who have sex with men (MSM), transgender population as well as people who 
injects drugs. These are key population especially vulnerable to HIV because they may engage 
willingly or not in behaviors involving frequent unprotected sex and the sharing of needles and 
syringes to inject drugs(“WHO | Data and statistics,” 2016). Furthermore, exploring those 
transmission categories, gay, bisexual and men who have sex with men are considered most at 
risk.(Merchant et al., 2016). People identifying as homosexual and bisexual accounted for 70% 
whereas, individuals infected through heterosexual sex made up 23% of all new HIV acquisitions. 
Global reports of 2014 also indicated that about 3.2 million children were living with HIV which 
comprises 9.1% of all people living with HIV (“HIV Survillance Report, CDC,” 2016). 
 In the Unites States more than 1.2 million people are living with HIV and, of those 1 in 8 
of the population are not aware of their HIV status. Six percent (2,392) of HIV diagnoses in the 
United States were attributed to injection drug use (IDU) and another 3% (1,202) to both male-to-
male sexual contact and IDU(CDC, 2015b) (Figure 1). Annual national survey on drug use and 
health conducted in 2013 has estimated 24.6 million Americans aged 12 or older used illicit drugs 
in past month, which consists 9.4 percent of the population (“Opioids | National Institute on Drug 
7 
 
Abuse (NIDA),” 2016). About 18.2 million population people from all over the world living with 
HIV have access to antiretroviral therapy (ART) (Figure 2) as of June 2016 which is up from 15.8 
million in 2015, 7.5 million in 2010, and less than one million in 2000 (“WHO | Data and 
statistics,” 2016). Untreated, HIV reduces the number of CD4 cells (T cells) in the body and 
continue to damage the immune system which makes it tougher to protect the body against 
infections. Reviews has shown the current gap in addressing some of the influential aspect 
including social stigma, social support and motivation to be impactful for HIV prevention.  
Reducing the incidence of HIV requires rapid and expansive primary HIV prevention 
strategies.(CDC, 2015) (“HIV Survillance Report, CDC,” 2016)(“WHO | Data and statistics,” 
2016). 
      
                  Figure 1- New HIV Diagnosis by transmission category 2015 [CDC Facts 2015] 
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   Figure 2 - Number of people on antiretroviral treatment (ART) [UNAIDS/WHO] estimates 
 
 
2.2 Substance abuse, HIV risk, and Pre-exposure prophylaxis treatment 
Substance abuse refers to a set of related conditions associated with consumption of mind 
and behavior altering substances that have negative behavioral and health outcomes. Social 
attitudes, political and legal responses to the consumption of alcohol and illicit drugs make 
substance abuse one of the most complex public health issues (“Healthy people 2020,” 2014). 
Although progress has been made in substantially lowering rates of substance abuse in the United 
States, use of substances continues to take a major toll on the health of individuals, families, and 
communities nationwide.(“Healthy people 2020,” 2014);(“Opioids | National Institute on Drug 
Abuse (NIDA),” 2016). Substance use can also contribute to these risks indirectly by lowering 
people’s inhibitions and making them less likely to use condoms.  
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Behaviors associated with drug abuse are also among the contributing factors in the spread 
of HIV in the US where injection drug use is responsible for approximately 10% of HIV cases 
annually (“National Institute on Drug Abuse (NIDA),” 2016). Effectively addressing high-risk 
populations requires supplemental efforts including providing them with tools such as condoms, 
PrEP care, and clean needles and syringes. In one study researchers found that 13.5% of 
participants reported currently injecting drugs and 82.3% had a history of injecting drugs with a 
higher prevalence of risk behavior among heroin injectors vs non-injectors (Tan, Kapiga, 
Khoshnood, & Bruce, 2015). In terms of gender differences in HIV risk behavior studies have 
shown an increased risk of HIV among the female participants, which was explained by injection 
partner being the same as the sexual partner(Evans et al., 2003). This shows the increase concerns 
regarding PWUD population as a high-risk group for HIV acquisition. 
Prior studies have shown that interventions providing information, enhancing risk-
reduction skills, and motivation the behavior change can reduce injection risk behavior.(M. M. 
Copenhaver, Lee, Margolin, Bruce, & Altice, 2011);(Kamarulzaman & Altice, 2015); (Wingood 
et al., 2004). PrEP represents a new biomedical approach to HIV prevention with the potential to 
become a powerful tool within the HIV prevention arsenal (HIV/AIDS, 2014)(Grant et al., 2010).  
Truvada is currently the only drug approved for use as PrEP consists of a single pill that is 
a combination of two ARVs, (tenofovir and emtricitabine). This prophylaxis drug was approved 
by the U.S. Food and Drug Administration (FDA) to treat HIV in 2004, and it was approved by 
FDA for use as PrEP in July 2012 (HIV/AIDS, 2014). Study trials have shown that when taken 
consistently and correctly, PrEP is very effective among high risk individuals. Recent study trials 
have also shown that, among gay and bisexual men, those who were given PrEP were 44% less 
10 
 
likely overall to contract HIV than those who were given a placebo, and it reduced the risk of 
contracting HIV by 62 % among heterosexually active men and women.(Grant et al., 2010).  
PrEP is a HIV prevention strategy that involves the daily use of ART by HIV-negative 
persons to prevent infection, but it also requires a multimodal, targeted approach including 
individual directed behavioral risk reduction approach to optimally prevent sexual transmission. 
In prior studies among injection drug users, the overall reduction of HIV infection was 49% and 
protection is increased to 75% among those who were on direct observation therapy during clinic 
visits (Choopanya et al., 2013); (Chariyalertsak et al., 2011). Antiretroviral medications markedly 
increase the survival of HIV infected persons and have long been the cornerstone of strategies to 
prevent vertical HIV transmission (Grant et al., 2010);(Chariyalertsak et al., 2011), and PrEP is 
now a significant step in the field of primary HIV prevention. 
A recent study representing national retail pharmacy shows that the individuals who started 
“Truvada” has a gradually increased in first year of availability with an estimated 150 unique 
individuals in 2011 to the 1057 in first 3 quarters in 2013(Flash et al., 2014). The data indicates 
that the female comprises 42% of PrEP users and tend to be significantly younger (36.4 +12.3) 
than males (39.3+11.6). PrEP users dropped to 22.9% later in 2013 (Flash et al., 2014). According 
to the new guideline by CDC, health care provider should consider advise patients to use the HIV 
prevention drugs only if they are at substantial risk of the HIV infection (CDC, 2015a).  
PrEP is a new primary HIV prevention approach that requires continuous collaboration 
between the high-risk individuals and providers in order to boost the effectiveness because near 
perfect adherence to PrEP is essential. The population-level effectiveness of PrEP will depend on 
its acceptability, accessibility, adoption, and sustainability as part of a comprehensive HIV 
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prevention strategy. Appropriate PrEP uptake among those high-risk populations, coupled with 
high medication adherence, will help maximize PrEP public health impact. 
 
2.2: Use of internet and Communication technology, PrEP and adherence self-
efficacy. 
Health information in the current society is one of the most rapidly sought topics on the 
internet so that people can seek health information and manage their own healthcare more 
independently (Curioso et al., 2007). Recent findings show that more than 70, 000 websites 
disseminate health information which has led to patients shifting their role from passive recipient 
to active consumer of health information. In relation to being a health information consumer, 50 
million people seek health information online, and this likely has consequences for the health care 
system (Beck et al., 2014);(Cline & Haynes, 2001). The internet offers widespread access to health 
information, and the advantages of interactivity, information tailoring, and anonymity. The 
majority of consumers (77%) seek health information for themselves and want disease information 
to use consultation with their physicians. Studies have shown that three quarters of online health 
seekers have made internet searches in conjunction with medical consultation. (S. C. Kalichman 
et al., 2006).  
The rate of internet use has been increasing and many people relied on the web information 
and aware of different diseases, prevention and its treatment. Information and communication 
technology such as internet and mobile phones can deliver behavioral components for STD/HIV 
prevention and care to more people at less cost (Curioso et al., 2007). High-quality health 
information can be provided through websites, forums, blogs, and social networks, which have 
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been some of the most popular channels for health promotion among young people in the past 10 
years (Beck et al., 2014). Prior studies have also shown that people who use internet for general 
purpose but also for health related purposes have demonstrated significant increase in self-
confidence about the information related to medication adherence (S. C. Kalichman et al., 2006). 
Among those people, skills and knowledge regarding HIV has also increased significantly.  
Furthermore, prior studies have reported those who use the internet for health care 
information have indicated that they experience improved knowledge about the illness, increased 
skills in coping, and greater support from others. (Van der Elst et al., 2013); (Kalichman SC, 
Cherry C, Cain D, et al.2006). Persons who used the internet for HIV related information were 
more likely to have an undetectable viral load compared to persons who had not used the internet. 
The disparities in internet use identified in this study suggest that individuals who access the 
internet, particularly for health information, are among the better resourced and healthier persons 
living with HIV/AIDS(Cline & Haynes, 2001). Analysis of internet and technologies users have 
shown that 26.6% (126/474) of participants reported utilizing online health information without 
seeking medical consultation. Further, 33.1%(157/474) reported they modified their healthcare 
based on the information they found on the internet(Beck et al., 2014). 
Although increasing number of people accessing internet reported from prior studies (Cline 
& Haynes, 2001), but lack of awareness among high risk populations have appeared as barriers for 
the accessibility and adoption of such powerful approach for HIV prevention. On the other hand, 
increasing trends of access of internet and its effective use had shown potential benefits to high 
risk people in terms of their self-awareness of health-related information. Improved information 
access through use of the internet and technology enhance the patients confidence in understanding 
of health condition making better health choices that leads to  improved health outcomes and 
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adherence to the preferred treatment.(Erik P. Bucy, 2008);(Murray et al., 2003); (Laugesen et al., 
2015).  
A cross sectional study on immediate PrEP uptake had shown that awareness on such a 
biomedical approach increased the ratio of participant’s interest in using PrEP, and that those on 
PrEP reported peer, internet, and their partners as their primary sources for treatment motivation. 
(Krakower et al., 2012). With respect to internet access, perceived health information from the 
internet has shown to be significantly linked with users adherence to the treatment (Laugesen et 
al., 2015). On the other hand, access to health information have positive effects on improving 
individual’s’ treatment decision making, development of sense of control over their health, and 
being connected to a broader community coping with similar illnesses (S. Kalichman, 2002). 
Therefore population-level effectiveness of PrEP will depend on its acceptability, accessibility 
(including via technology), adoption, and sustainability as part of a comprehensive HIV prevention 
strategy. 
 
2.4: Motivations, Pre-exposure prophylaxis and adherence self- efficacy 
2.4.1: Social support and motivation 
Antiretroviral medications markedly increase survival of HIV infected persons and have  
been the cornerstone of strategies to prevent vertical HIV transmission (Grant et al., 2010); 
(Chariyalertsak et al., 2011).Studies have shown that, despite the low utilization of PrEP, low self-
perceived knowledge of PrEP, and a high prevalence of condom less anal intercourse, fewer than 
half of those same participants were interested in learning more about PrEP. (Merchant et al., 
2016). Furthermore, recent studies have shown that, motivations were highest among men who 
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reported condom-less sex with both their primary and outside partners whereas, and  lowest among 
men who had sex only with their primary partner (Gamarel & Golub, 2015).  A prior intervention 
study among young MSMs demonstrated  an increase in skills and knowledge regarding HIV, 
although the intention to use PrEP was associated with lower condom use among the study 
population (Bauermeister, Meanley, Pingel, Soler, & Harper, 2013). 
 In addition, descriptive studies have revealed that their past experience on taking 
medication was linked with adherence self-efficacy. Some participants of these studies have 
indicated their worries about the effectiveness and difficult in adhering to PrEP (Van der Elst et 
al., 2013); (Bil, van der Veldt, Prins, Stolte, & Davidovich, 2016).  
Reductions in high-risk sexual behaviors to date have been based on theoretical models 
such as the Social Cognitive Theory (Bandura, 2004), addressing personal self-efficacy, assessing 
ability and willingness to modify behavior in injection drug users (IDUs) with HIV. Likewise, the 
Information-Motivation-Behavioral Skills Theory (Fisher, Fisher, Williams, & Malloy, 1994) 
which conceptualizes determinants of behavior that have the capacity to impair or improve health 
status. Findings reported on adherence self-efficacy and healthy behavior modification involves 
various components which influence its change through educational, motivational, peer-guided, 
and skill-building techniques (Coates, Richter, & Caceres, 2008). 
Lack of awareness and feasibility of HIV treatment serves as a barrier to PrEP and also 
illustrates that behavior counselling and motivation are essential to increase in the adherence for 
PrEP use (Bauermeister et al., 2013). Prior studies on PrEP had shown lower adherence self-
efficacy as an outcome of increased perceived medication side effects, whereas significantly 
positive outcomes have been associated with social stigma. (Zhang et al., 2016). Recent study 
results had indicate that social support is one of the predictor of higher medication adherence and 
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self-efficacy (Turan et al., 2016). Intention to use PrEP, however has been shown a negative effect 
on risk reduction self-efficacy.  
Likewise, predictors of ART adherence among minority population shows that that lower 
self-efficacy was related to lower social support and motivational readiness was predicted by 
higher adherence self-efficacy (Kolmodin MacDonell, J. Jacques-Tiura, Naar, & Isabella 
Fernandez, 2016). Thus it is essential to explore the effects of motivation factors for PrEP use on 
individual’s adherence self-efficacy as well as the impact of social and personal motivations on 
new biomedical approaches for HIV prevention.  
 
2.4.2: Attitude towards pre-exposure prophylaxis treatment and intention 
motivation 
Due to the socially marginalization of the people who injects drugs it is also unpalatable to 
provide adequate health services to those population.(UNAIDS, 2014). Such stigmatized and 
discrimination were considered as a major barrier in their willingness or intention to adopt 
biomedical intervention and treatment. So, peer network and their motivation had a great impact 
on improving knowledge, positive attitude regarding HIV prevention and accessing to health care 
services. Study reports had shown that high intention to use PrEP is associated with the low 
perceived self -efficacy(Cohen et al., 2015).Adherence  to PrEP use is critical aspect and strongly 
associated with efficacy of the medication. Researchers have found that PrEP adoption intention 
is also associated with the risk perception. Therefore, in order to facilitate the PrEP adoption, 
community awareness and information have shown its significant role which address the 
perception among high risk individuals.(Brooks et al., 2012). Assessment on the Pre exposure 
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Prophylaxis and their association with PrEP adoption demonstrated that only 33% of total 
participants were aware of PrEP (Brooks, Landovitz, Regan, Lee, & Allen, 2015). Further, lower 
PrEP adoption were associated with negative perceptions regarding PrEP which may limit its 
uptake among those high-risk population. 
One study(Copeland et al., 2017) illustrated that less than half of the participants were 
“very” or “extremely” familiar with the biomedical interventions such as microbicides, PrEP and 
other experimental vaccines. Further questions related to familiarity with those treatments, 
knowledge and attitudes were answered correctly less often (73%, 54%, and 45%, respectively. 
Moreover, higher overall knowledge scores were related to more positive attitudes regarding PrEP 
than those with less positive attitudes. Additional assessment from the randomized control trials, 
demonstrated the acceptability of PrEP but PrEP adherence were not up to the expectations.(Grant 
et al., 2010) ;(Hoff et al., 2015) (grant M , Hoff).  
Researchers have found that, among HIV negative couples, partner support can  increase 
the positive attitude about PrEP and potentially help with the PrEP use intention and adherence 
(Hoff et al., 2015). Although the results of the trials were in a the promising directions, a better  
understanding of  variables that impact which attitude, intention and adoption of  PrEP is a priority 
in present situation (Jayakumaran et al., 2016);(Zhang et al., 2016);(Arnold et al., 2017). Positive 
intention and appropriate risk perception regarding HIV transmission and prevention may play a 
key role in PrEP adherence and the development of  PrEP treatment and adherence self-efficacy 
(Mey et al., 2017a); (Jayakumaran et al., 2016);(McCormack et al., 2016). 
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2.4.3: Neurocognitive impairment, depression, and adherence self- efficacy 
The adherence to the medication is crucial self-care behavior for people living with HIV 
as well as for optimal benefits of high risk individuals. In relation to self-efficacy, it is associated 
with  health related behavior along with medication adherence like ART, and PrEP treatment in 
the  context of HIV (McCormack et al., 2016). The prevalence of human immune deficiency virus 
has given rise to a new spectrum of neurocognitive and psychological impairment which hinders 
those individuals for the utilization of the available treatment and prophylaxis measures for 
prevention of the HIV(Meade et al., 2011);(Cross, Combrinck, & Joska, 2013). The core construct 
of the social cognitive theory applies to confidence in engaging in behaviors leading to the desired 
outcomes.  
In the context of ART adherence self-efficacy and an individual’s psychosocial aspect, 
studies among HIV infected individuals with higher adherence self-efficacy consistently 
demonstrate lower depression status. Likewise, analysis findings also reported low adherence self-
efficacy resulting in poor health outcomes (Johnson et al., 2007); (Bandura, 2004). In regards to 
neurocognitive complication, a retrospective study among HIV infected people with ART 
treatment has shown deterioration of the neurocognitive abilities and depressive mood compared 
to HIV-sero-negatives individuals (Mey et al., 2017b).  
In addition, studies have also shown that further impairment in verbal, auditory and 
learning abilities which have been observed  among drug and alcohol users interferes with health 
management, high order thinking and medication adherence. (“Opioids | National Institute on Drug 
Abuse (NIDA),” 2016);(Carroll et al., 2016). Another study examining the relationship between 
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neurocognitive functioning and medication adherence has reported that drug dependence acts as 
mediator of cognitive function leading toward  poor adherence (Meade et al., 2011).  
A cluster randomized control trial has shown that the alleviation of the depression is 
improved with high adherence self-efficacy and also mediated by higher adherence motivation for 
the treatment (Wagner et al., 2017). Limited studies have gone in depth to examine the impact of 
depression and cognitive functioning on ART and other types of HIV treatment adherence, such 
as PrEP. However, there is reason to predict that of the improvements in motivation and self-
efficacy that may translate to enhanced of adherence self -efficacy and self-care health behaviors 
for HIV prevention. 
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CHAPTER 3: RESEARCH QUESTION AND HYPOTHESES 
 
Research Questions 
1. Does motivation for PrEP predict PrEP adherence self-efficacy among high risk drug 
users? 
2. Does technology & internet use and psychological factors (NCI and Depression) have a 
potential influence on PrEP adherence self-efficacy? 
 
Research Hypotheses 
      The following hypotheses will be tested in this study to see the potential influence of 
motivation, internet & technology use along with psychological factor on confidence in developing 
PrEP adherence among high risk drug users. 
Hypothesis 1: Motivation for PrEP use predicts PrEP adherence self-efficacy. 
Hypothesis 2: There will be a significant relationship between the use of technology and internet 
and PrEP adherence self-efficacy. 
Hypothesis 3: There will be a significant impact of NCI and depression on PrEP adherence self-
efficacy. 
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CHAPTER4: METHODS 
4.1 Design 
This is a secondary data analysis of a pilot study of PrEP treatment approach conducted 
among sample of high risk drug users enrolled in Methadone Maintenance Treatment (MMT). The 
pilot study design was cross-sectional survey method using a convenience sampling approach. The 
sample data were collected by trained graduate research assistants and clinical research facilitators.  
 
 
4.2 Participants 
A total of 400 participants were recruited using convenience sampling between June and 
July 2016 at the APT Foundation, Inc., in New Haven, CT. The eligible criteria for the study were, 
a) 18 years or older, b) HIV-negative, c) reported drug- or sex-related HIV risk behaviors in the 
past 6 months, d) met DSM-V criteria for opioid use disorders (OUDs), e) enrolled in MMP, f) 
able to understand, speak, and read English, and g) able to provide informed consent. A total of 
438 participants completed the initial screening form, twenty-eight were screened out because they 
did not meet eligibility criteria. Of those who were eligible to participate (n=410), one participant 
did not complete the survey and nine did not agree to participate in the study. Therefore, the final 
sample size included 400 participants in this study. 
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4.3 Study setting and procedures 
  This cross-sectional study was conducted among high-risk drugs users within APT 
Foundation, which is a community-based facility in New Haven, Connecticut that provides drug 
treatment and clinical care to opioid- dependent adults. Participants were recruited via flyers, 
peers, word-of-mouth, and direct referral from counselors at APT Foundation. Individuals who 
met inclusion criteria, and who were willing to participate, were provided a description of the study 
and invited to provide informed consent, followed by the study survey. Participants were assessed 
using audio computer assisted self-interview (ACASI) which has demonstrated sound 
psychometric properties in prior studies(M. M. Copenhaver et al., 2011) and controlled trials(M. 
M. Copenhaver, Lee, & Margolin, 2007).  All participants were reimbursed for the time and effort 
needed to participate in the survey. 
 
4.4 Measures 
          Participant’s demographics were collected including age, gender, sexual orientation, 
ethnicity, marital status and educational status. Other variables of interest were motivations for 
PrEP, use of internet and technology, NCI, depression and PrEP adherence self- efficacy. 
 
 
4.4.1 Motivations for PrEP 
  Motivations for PrEP use was assessed a 16-item questionnaire. For the validation of the 
questionnaire exploratory and confirmatory factor analyses were conducted and their model fit 
estimates and significance were examined (see Appendix Table8, Table 9). Participants were 
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assessed for their social motivation (e.g., “I have family members or friends to encourage me to 
take PrEP properly.”), intention motivation (e.g., “If I were on PrEP, taking it properly as 
prescribed would be hard”)  and attitude towards PrEP (e.g., When on PrEP, I don’t need to use 
new or clean needles) all on a 5-point Likert scale (ranging from 1 = ‘strongly disagree’ to 5 = 
‘strongly agree’).The reliability of the three domains of motivation that resulted from the EFA and 
CFA were within acceptable range (by factor social motivation α=0.72, intention motivation α 
=0.82, attitude toward PrEP α=0.72). Higher scores indicated greater motivations. 
 
4.4.2 Use of the internet 
Participants were assessed for their use of internet for health information which was 
measured with 7 items on a 5-point Likert scale (ranging from 1 = ‘never’ to 5 = ‘all the time’) 
(S. Kalichman, 2002). In order to measure internet use, the following items were included. Do 
you: 1) Access the internet across all your devices? 2) Search the web for general information? 3) 
Search the web for health-related information? 4) Search the web for HIV-related information? 5) 
Search the web for HIV experiences, treatment? 6) Search HIV-related news articles? 7) Search 
online for sexual partners?  Scores ranged from 1 to 35 with higher score indicating higher use of 
internet. The mean score on these questions was computed and the reliability of the items were 
tested (Cronbach alpha =0.759) which indicated the reliability of these questions used. 
 
4.4.3 Use of communication technology device 
           Participants were also assessed for their use communication technology device for health 
information. An adapted version of a questionnaire (Krishnan et al., 2015);was used to measure 
participants’ access to and frequency of using various types of communication devices (e.g., 
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landline telephone, cell phone, tablet, laptop, personal computer, etc.). Participants were asked 
how often they use various types of communication technologies on a 5-point Likert scale (ranging 
from 1 = ‘never’ to 5 = ‘all the time’) (Shrestha, Huedo-Medina, Altice, Krishnan, & Copenhaver, 
2016). The mean score on these questions was computed and the reliability of the items were tested 
(Cronbach alpha =0.853) which indicated the reliability of these questions. Higher scores indicated 
greater use of technology device for health information. 
 
4.4.4 Neurocognitive impairment (NCI) 
          Neurocognitive impairment status of the participants was evaluated using the Brief 
Inventory of Neurocognitive Impairment (BINI). The BINI is a brief, self-report measure of 57-
items and 9 factors which have demonstrated excellent overall reliability (α=0.97) (M. 
Copenhaver, Shrestha, Wickersham, Weikum, & Altice, 2016). It is a convenient tool developed 
as a rapid way to elicit diagnostically relevant information about generalized NCI which is 
categorized as “Global Impairment” as well as specific symptom areas (e.g., attention, memory, 
linguistic functioning, etc.). The Global Impairment factor is measured by 22 items (e.g., “I have 
difficulty paying attention” and “I get lost easily”), A Language-related factors included 5 items 
(e.g., “My words get mixed up”), Memory-related factor includes 4 items (e.g., “I have trouble 
remembering people’s names”), Academic-related factors consists of 8 items (e.g., “I count with 
my fingers” and “I have trouble learning new things”), while the psychomotor/physical question 
contained 5 items (e.g., “I am very”) clumsy and the Psychomotor/perceptual related factors 
comprised of  5 items (e.g., “I have trouble with the left side of my body”). The anger-related had 
3 items (e.g., “I have urges to break and smash things”), the Pain-associated included 3 items (e.g., 
“I have severe headaches”), and the Traumatic Head Injury-related had 2 items (e.g., “I have been 
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knocked unconscious”). The overall BINI score was obtained by summing responses to all items. 
The nine factors ranged from good to excellent reliability (by factor: F1 α=0.97; F2 α=0.89; F3 
α=0.82; F4 α=0.76; F5 α=0.79; F6 α=0.75; F7 α=0.75; F8 α=0.74; F9 α=0.73). 
 
4.4.5 Depression 
Patients’ depressive symptoms over the previous week were assessed using the Center for 
Epidemiological Studies Depression Scale (CES-D). The (CES-D) is a 20-items self-report 
screening measure for depressive symptoms that has demonstrated excellent reliability and validity 
(Shrestha, Weikum, Copenhaver, & Altice, 2017). The items were rated on a 4-point Likert scale 
with 0 = rarely or none of the time (less than 1 day); 1 = some or little of the time (1–2 days); 2 = 
occasionally or a moderate amount of the time (3–4 days); 3 = most or all of the time (5–7 days). 
Total sum scores range from 0 to 60, with higher scores indicating increased levels of depression. 
Examples of questionnaire items used to measure depression were: 1) During the past week, you 
were bothered by things that usually don’t bother you. 2) During the past week, you did not feel 
like eating; your appetite was poor. 3) During the past week, you felt that you could not shake off 
the blues even with help from family or friends.4) During the past week, you felt that you were 
just as good as other people. 5) During the past week, you had trouble keeping your mind on what 
you were doing. The overall internal consistency (Cronbach’s alpha =0.864) for the entire 20-item 
scale questionnaire. 
 
4.4.6 PrEP adherence Self- efficacy 
  Participants were assessed with a set of 11 questions regarding PrEP adherence self-
efficacy on 5-point Likert scale (ranging from 1 = ‘not at all confident, 5 = ‘very confident’) 
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(Shrestha, Altice, et al., 2017). Examples of the items used to measure PrEP adherence self -
efficacy were: 1) How confident are you that you would remember to take PrEP every day? 2) 
How confident are you that you would stick to your PrEP medication even if you have some side-
effects? 3) How confident are you that you could make PrEP part of your daily routine? 4) How 
confident are you that you could get PrEP refills before you run out? 5) How confident are you 
that you could fill your PrEP prescription no matter what it costs? 6) How confident are you that 
you could continue with your PrEP regimen even when people close to you say it isn’t good? 
Scores ranged from 1 to 55 with higher score indicating higher adherence self-efficacy. The mean 
score on these questions was computed. The overall internal consistency for the entire 11-item 
scale was high (Cronbach’s alpha= 0.887).  
 
4.5 Data Analysis 
Data were analyzed using the statistical software (SPSS) Statistical Package for the Social 
Sciences, version 23.0[64] and R lavaan version 3.3.1 (see Appendix). A test of normality along 
with its graphical representation of the dependent variables were conducted. Tests for normality 
was carried out with a one-sample Kolmogorov Smornov normality test. Histogram and Q-Q plot 
were  used to specify the normal distribution pattern. Assumptions of the regression (linearity and 
homoscedasticity) were examined for the analysis. In order to check this assumption, the 
scatterplot of standardized residuals against standardized predicted values were plotted. Likewise, 
normality of residuals was examined by histogram and normal probability.  
Descriptive statistics of the demographics along with other variables of interest which 
includes frequency, mean and percentages among variables of interest were provided by using 
SPSS software. The principle component analysis with “varimax” rotation, exploratory factor 
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analysis with four factors followed by confirmatory factor analysis were conducted. The model fit 
was determined with “Comparative fit index” and RMSEA (root mean square error of 
approximation) using the Lavaan package. The goal of this analysis was to sort out the different 
component of motivation for PrEP for validation of the components question. 
In order to test our hypotheses, we conducted general linear regression for psychological 
variables and use of internet and technology. In the regression model, PrEP adherence self-efficacy 
was regressed with internet use, use of technology device, NCI and depression independently. 
Whereas multiple regression analyses were conducted for motivation for PrEP adherence self-
efficacy, in this model, PrEP adherence self-efficacy was regressed with three factors of motivation 
(social motivation, intention motivation and attitude towards PrEP) controlling for demographic 
variables (age, gender, sexual orientation, ethnicity, marital status and educational status) due to 
their non-significant associations with the outcome variables. 
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CHAPTER 5: RESULTS 
5.2: Descriptive Statistics 
A total of 400 participants were included in the data analysis which consisted of 234 males 
(58.5%) and 166 females (41.5%) with mean age of (40.9). (Table1). The majority of participants 
were identified as heterosexual or straight (86.3%) and obtained minimum of the high school 
education (4.3%). The recruited participants were White (63.2%), African American (17.5%), 
Hispanic or Latino (15.3%) and other race (4%) (Table1) which indicates that the majority of the 
sample consists of white high-risk drug users. 
The summary statistics (Table2) exhibits the mean scores from the predictor and outcome 
variables. A one-sample Kolmogorov Smornov normality test was carried out for the dependent 
variable PrEP adherence self-efficacy which shows a non-significant (p=0.06) indicating the 
hypothesis of normality was not rejected. Along with the normality test, the histograms(Appendix 
Figure 3) of the dependent variable showed the distribution is approximately normal. Likewise Q-
Q plots have also shown the variables fall on the a linear trend (Appendix Figure 4) which supports 
the assumption of normal distribution. 
As regression models should be assumed to have constant variance of the residuals 
(homoscedasticity), this assumption was examined. The scatterplot of standardized residuals 
against standardized predicted values plotted for PrEP adherence self-efficacy (see Appendix 
figure 5) shown that they were randomly scattered which verifies the assumption of 
homoscedasticity. The histogram and normal probability plot also shows whether there are 
deviations from normality. The bell-shaped curve of the histogram (Figure 6, Figure 7) and the 
probability plot (Figure 8) indicate the assumption of normality of residuals is met. 
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Table 1 Demographic characteristics of participants (n=400) 
 
          Variables 
 
 N Percent (%) 
Gender  Male  234 58.5 
  Female  166 41.5 
Ethnic group  White  253 63.2 
  African American or Black  70 17.5 
  Hispanic or Latino  61 15.3 
  Other  16 4 
Marital status Married  83 20.8 
 Divorced 65 16.3 
 Separated 46 11.5 
 Widowed 14 3.5 
 Never married 192 48.0 
Sexual orientation Heterosexual  345 86.3 
 Homosexual 9 2.3 
 Bisexual 39 9.8 
  Other 7 1.8 
Education Middle School   17 4.3 
 High School,   90 22.5 
 High School Graduate / GED 
or Equivalent 
172 43.0  Junior (2-year) College  20 5.0 
 Technical School  25 6.3 
 College   62 15.5 
 College Graduate   14 3.5 
In last 3months 
Primary Method of 
illicit opiate use. 
IV Injection 160 40 
Smoke 115 28.7 
Snort 47 11.8 
Oral 10 2.5 
Non-IV injection 2 5 
Age Mean (40.9 ± 11.08)   
 Total  400 100.0 
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Table 2 - Summary statistics of motivations, internet and technology use, NCI and depression 
     
 
 
 
 
 
 
 
 
Note: a  Standard deviation 
 
5.3: Factor Analysis 
      Motivation for PrEP was measured using a Likert scale with 16 questions which consisting of 
various motivational components such as social motivation, motivation intention and attitude 
towards PrEP. In fitting the initial constructs, primary component analysis (PCA) was conducted 
using proportion of variance greater than or equal to (0.1). The PCA analysis indicated four 
possible factors to improve the fit of the model. Likewise, the exploratory factor analysis (EFA) 
determined a reduced number of items derived from higher factor loadings (Factor loadings >0.5) 
(see Appendix Table 8). Modifications of the constructs from the EFA resulted in 10 items of 
motivation domains which then were included in the confirmatory factor analysis (CFA) for the 
validation of the model fit.  The confirmatory factor analysis (CFA) model yielded a good model 
 
Variables 
N=400  
Mean ± S.Da Min Max 
Social motivation 0 04 2.26±0.75 
0.84±0.75 
2.53±0.83 
25.36±10.08 
Intention Motivation  0 04 
Attitude  0 04 
Use of technology device  07 42 
NCI 57 258 133.09±44.71 
24.33±10.88 
16.84±4.65 
23.88±8.72 
Depression 0 51 
Use of Internet  07 35 
PrEP adherence self-efficacy 0 44 
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fit with [p<0.05, Comparative Fit Index (CFI) =0.95, [RMSEA 0.06] which is within an acceptable 
model fit range (Appendix Table 9). Further, a 95% confidence interval [CI (0.05, 0.08)] shows 
the lower range (<0.08) suggesting the acceptable model fit for the motivation for PrEP 
components (Table 9). The factor loadings of the CFA of the motivation domains included, social 
motivation, intention motivation and attitudes towards PrEP. The reliability of the three domains 
of motivation that resulted from the EFA and CFA were within acceptable range.  
 
 
5.4: Regression analysis 
5.4.1 Influence of motivation for PrEP use on adherence self -efficacy 
        A multiple regression analysis was conducted (Table 3) with general linear model while 
controlling demographic variables. This involved three motivation factors with their mean scores. 
Following the factor analysis of the motivation question we examined the potential effect of those 
factors on PrEP adherence self-efficacy. The analysis showed that motivation predicts PrEP 
adherence self- efficacy as hypothesized. The collinearity test has shown that there was no multi-
collinearity among the variables [variance inflation factor VF<3(1.19, 1.21, 1.04)] (Table 3). 
Higher social motivation or social support (β= 0.32, p =0.00) (table 3), predicts adherence self- 
efficacy.  
Participants who indicated that they were had been motivated by family members, peer 
values among high risk drug users to take PrEP were more confident about being in PrEP. 
Similarly, attitude about PrEP use was also statistically significant (β=0.139, p=0.00) (Table 3) 
which indicates that positive attitude towards use of PrEP, was related to higher adherence self-
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efficacy. In terms of intention motivation for PrEP there was an inversely proportional relationship 
(β= -0.24, p<0.05) (Table 5) with PrEP adherence self-efficacy. 
            These results suggest that social support and positive attitudes towards HIV prophylaxis 
treatment among high risk drug users were associated with participants ‘confidence in adherence 
to treatment. On the other hand, increased in intention motivation was related to lower PrEP 
adherence self-efficacy which may refer to decreased risk perception about HIV transmission and 
engaging in high risk behavior. The model summary of the regression analysis shows the 
motivation factors (social, intention and attitudes) as the potential predictors of PrEP adherence 
self -efficacy (R2=0.168), which shows that 16% of the adherence self-efficacy variance is 
explained by motivation factors. 
 
Table 3 - Regression analysis of social motivation, intention motivation and attitudes for 
PrEP on adherence self-efficacy 
Variables Coefficient Std. Error P<0.05 VIF<3a 
Social motivation  0.30 0.05 0.00* 1.19 
Attitude towards PrEP  0.14 0.05 0.00* 1.20 
Intention motivation  -0.24 0.05 0.00* 1.04 
Age 0.00 0.00 0.43 1.09 
Gender 0.08 0.07 0.25 1.08 
Sexual orientation 0.02 0.05 0.73 1.07 
Ethnic 0.05 0.04 0.15 1.04 
Education -0.01 0.02 0.75 1.05 
Employment 0.01 0.02 0.64 1.07 
Note: 
a VIF = variance inflation factor<3 
*p<0.05 
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5.4.2 Influence of internet use for health-related information and use of 
technology devices on PrEP adherence self-efficacy 
  Table 2 shows that participants reported significant use of the internet use (mean =2.6) and 
it was frequently used to search for health-related information, sexual partner and information 
related to HIV related prevention and treatment. The reliability of the questionnaire was tested 
(Cronbach alpha =0.76, α >0.7) which implies acceptable reliability among the items used. In order 
to detect the influence of internet use and use of technology devices on PrEP adherence self-
efficacy, a linear regression model was used to fit the data. This showed that participants who 
reported more use of the internet for HIV and health related information were more likely to have 
higher PrEP adherence self-efficacy (β=0.09, p=0.02) (table 4). Analyses also showed that 
participants who reported use of technology devices for the mode of communication and 
information reported higher adherence self-efficacy (β=0.21, p<0.05) (Table 4). These findings 
suggest that use of communication technology and internet may potentially have significant impact 
on high risk individuals being aware of HIV prevention and treatment along with enhancement of 
self confidence in utilizing biomedical approaches to reduce the possibility of HIV acquisition. 
Table 4 - Regression analysis on use of internet and technology device on PrEP adherence 
self -efficacy 
Variable   Coefficient Std. Error t P<0.05 
 
Use of Internet  
 
       
        0.09 
 
0.04 
 
2.40 
 
0.02* 
Use of Technology 
device  
       0.21 0.05 4.03 0.00* 
*p<0.05 
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5.4.3 Influence of Psychological factor on PrEP adherence self- efficacy 
          We also examined two psychological variables NCI (Neurocognitive impairment) and 
Depression as a predictor variable of PrEP adherence self-efficacy. Regression analyses were 
conducted to determine the potential influence of these variables. The analysis revealed that NCI 
was not a significant predictor of PrEP adherence self-efficacy (β=.03, p=0.52) (Table 5), while 
controlling for demographic variables as covariates. Similarly, we also examined the effects of 
depression while controlling for demographics. In this case, depression was found to be marginally 
associated (β=0.15, p=0.04) (Table 6) with adherence self- efficacy. In the combined model of 
psychological factors for PrEP adherence, however NCI beta coefficients showed a higher score 
with NCI associated with lower adherence self-efficacy (β= -0.37, p>.05) (Table 7). A positive 
association was found with depression, but it was not statistically significant (β= 0.16, p>0.05). 
 
Table 5 - Regression Analysis on NCI and PrEP adherence self- efficacy 
 
Variables Coefficient        Std. Error t P<0.05 
NCI 0.03 0.05  0.65 0.52 
Age 0.00 0.00 0.63 0.53 
GENDER 0.13 0.08 1.48 0.14 
Sexual orientation 0.01 0.06 0.09 0.93 
Ethnicity 0.03 0.04 0.70 0.48 
Education 0.01 0.03 0.39 0.69 
Employment -0.01 0.02 -0.30 0.76 
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Table 6 - Regression Analysis on depression and PrEP adherence self-efficacy 
Variables Coefficient        Std. Error t P<0.05 
Depression  0.14 0.07 1.98 0.048* 
*p<0.05 
 
Table 7 Combined model of depression and Neurocognitive impairment on PrEP 
adherence self-efficacy 
 
Variables Coefficient      Std. Error t P<0.05 
NCI -0.04 0.07 -0.55 0.58 
Depression 0.16 0.09 1.68 0.09 
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Chapter 6: Discussion 
              The goal of this study was to examine the potential influence of motivation, internet use, 
communication technology and psychological factors on PrEP adherence self-efficacy among high 
risk drug users. When the socio demographics were examined it revealed that the population 
distribution among the included categories were not in equal proportion, therefore, no any 
significant associations were ruled out with the outcome variable. (Table1). The regression 
analyses, however, were conducted after controlling for the demographic variables. Recent  studies 
have  also found similar results with regard to the impact of motivation on PrEP adherence and 
risk behaviors (Bauermeister et al., 2013);(Mey et al., 2017b).  
In this study, various constructs of motivation have been yield with a good model fit 
conducted using EFA and CFA. We found the derived constructs of motivation were significantly 
associated with PrEP use and predicted higher adherence self-efficacy, with the exception of 
intention motivation resulted in a negative relationship with PrEP adherence self-efficacy. Prior 
studies have predicted the positive effects of social motivation and attitude(Brooks et al., 2012); 
(Khumsaen & Stephenson, 2017), whereas higher perceived HIV risk or perceived severity of 
disease resulting in lower adherence self-efficacy. With regards to prior findings, intention to use 
PrEP is highly associated with increased risk behavior, there exists a intention and risk behavior 
relationship that concerns the need to explore intervention in future to bridge the gap. Our study 
findings support the hypotheses and expands upon the existing literature on factors of motivation 
including social support, intention motivation and attitude reported among high risk drug users.  
When we examined the linear regression analyses, it indicated that decrease in intention 
motivation appears to be associated with to the personal motives of individual and their perceived 
36 
 
high risk for HIV predicted increase PrEP adherence. In relation to, low perceived side effects of 
medication, low perceived risk regarding PrEP treatment individuals were more likely to be on 
treatment. Our study extends another construct of motivation (social motivation and attitudes) as 
significant predictors of individual PrEP adherence self-efficacy This PrEP survey supports the 
findings of prior studies by showing that the family and peer support can play a positive role in 
encouraging high risk people to develop greater adherence self-efficacy. Thus, these finding may 
be an important aspect of developing new intervention approaches among high risk drug users and 
other high-risk groups.  
Because an increasing number of high risk groups, lack of awareness of HIV prevention 
related information, this has caused significant barriers related to their accessibility to and adoption 
of such powerful approaches that can prevent HIV among currently HIV negative people. Our 
study findings revealed that participants who reported being involved in use of internet and 
technology were more likely to obtain information relevant to HIV prevention and PrEP which 
may be useful in reducing barriers stemming from a lack of relevant information. In this study, we 
found that internet use focused on high risk individuals, gathering HIV prevention information and 
searching for health-related treatment including PrEP. Findings from our study also show that 
participants who use the internet as the source of such information tend to have higher PrEP 
adherence self-efficacy. Thus, internet search of informational content regarding HIV, prevention 
and current treatments has the potential to provide valuable knowledge to keep people informed 
about the effective interventions.  
Some studies have assessed internet use among youths populations and found it to be 
effective at improving knowledge and skills (Hightow-Weidman et al., 2015). In terms of 
communication and technology, use of various communication devices woks along with  access 
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to the internet which aids in developing the knowledge and appropriate information to different 
group of people (Laugesen et al., 2015). We found participants were more likely to have 
smartphones with internet access other than laptops and PCs. In the study, we examined the use of 
technology device and found that the more likely the use of technology device the higher the 
predicted higher adherence self-efficacy. Thus, thesis findings highlight the importance of 
awareness on HIV transmission and its different preventive approach on developing skills that 
benefits the individual to promote self confidence in such HIV prevention approaches. It is 
important to note that lack of information about HIV prevention and adoption of PrEP can leads 
to high risk behavior and lowers the chances of PrEP adherence.  
Analyzing the components of the Information-Motivation-Behavioral model with respect 
to the study findings, information and awareness regarding PrEP treatment tended to impact 
participants’ adherence self-efficacy. The findings have revealed that individuals’ use of internet 
information and communication through technological device is a source of primary information 
regarding HIV treatment, rather than participating in typical intervention program designed to 
target treatment adherence. On the other hand, the study also indicates the importance of various 
types of motivation in association with PrEP adherence self-efficacy. In comparison to other high-
risk populations results shown a similar pattern of associations, but it is yet to be explored whether 
there are significant differences across risk groups in terms of PrEP adherence.   
With respect to psychological factors, a non-significant statistical difference was evident 
in terms of the potential influence of NCI on PrEP adherence self-efficacy. However, the influence 
of depression in our sample of high risk drug users was found to be marginally associated with 
PrEP adherence self-efficacy. These findings suggest that there is may be an influence of some 
psychological factors on PrEP adherence self-efficacy but have not shown a statistically significant 
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relationship in our data. In the combined model, including both NCI and depression, psychological 
factors have shown a non-significant association. These study findings of non-significant as well 
as negative association of NCI with PrEP adherence suggest that the presence of different cognitive 
deficits might be a barrier to PrEP adherence to some degree. Although prior studies have 
demonstrates that higher NCI is related to lower self-efficacy (Shrestha, Weikum, et al., 2017); 
(Anand et al., 2010), no  such pattern was found in this analysis, whereas, it supports other studies 
reporting similarly marginal significance levels (Wagner et al., 2011) of depression and its impact 
on PrEP adherence self-efficacy. 
Overall, the findings from this study supported prior research finding but the majority of 
those studies were conducted among MSM populations. To the best of our knowledge, our study 
is the only one to find the potential predictors of PrEP adherence self -efficacy among people who 
use drugs. We have found that different domains of motivation play different role in developing 
self- efficacy in an individual. Results also showed that use of technology and internet access may 
be one of the component that is essential in promoting information exchange among different and 
facilitating their make awareness of current treatment approaches and their effectiveness. A better 
understanding of the emergent issues inherent in the provision of PREP will allow for the 
development of both individual-level interventions supporting PREP users and community-level 
interventions designed to increase awareness and acceptability of PREP. 
6.1 Limitations 
This study had some limitations which deserve attention in terms of interpreting the findings 
presented here. First, the study methodology was cross sectional which greatly limits the potential 
to make cause and effect conclusions.  Second, self-report assessments were used in this study and 
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this may have impacted our ability to correctly determine outcomes due to biases associated with 
self-report of socially undesirable behaviors. Another limitation might be the impact of 
demographic characteristics such as age, gender, income and education. The association of PrEP 
use intention with high HIV risk acquisition in this cross-sectional study might be a limitation 
among the participants with need of immediate intervention to eliminate the high-risk behavior. 
Finally, this study was specific to high risk drug users participating in a methadone treatment 
program and this may restrict our ability to generalize the findings to other populations and to 
different settings. Despite these limitations, and others the study findings provide important 
information pertaining to PrEP adoption/adherence self-efficacy as influenced by motivation and 
the use of internet. 
 
 
Chapter 7: Conclusions 
People who use drugs have always been at risk for the HIV infection around the globe 
despite numerous promising HIV intervention approaches. Of particular note, however, the 
demand for PrEP treatment is rising among high risk populations, which has the potential for 
preventing a substantial amount of HIV acquisition and subsequent transmission. The lack of the 
motivation and current awareness hinders many high risk individuals from the benefits of such 
innovative preventive approach(Carroll et al., 2016). On the other hand, the increasing trends of 
access to the internet has shown the potential benefits to the high-risk people in terms of greater 
awareness about new HIV prevention approaches.  
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Prior studies have demonstrated the high adherence to PrEP treatment was associated with 
low perceived risk of HIV which are more likely to be socially determined. Although clinical trials 
for the HIV prevention among MSM are now underway, PrEP was unfamiliar to the high risk 
sample. On the other hand, the potential for the rapid uptake of the PrEP among various priority 
populations seems feasible. Findings collected from other studies (Krakower et al., 2012); (Bil et 
al., 2016); (Bauermeister et al., 2013) has raised concerns on that the evolving awareness and the 
utilization of the PrEP is associated with the behavior deterioration which could lead to the lower 
risk perception and might reduce the motivation to engage in risk reduction. Therefore this study 
analysis will provide considerable empirical evidence on potential impact of those motivation 
factors on adherence self-efficacy of Pre-exposure prophylaxis treatment.  
Despite of widespread utilization of ART there are high prevalence of neurocognitive 
impairment, depression and other psychological factors among people who use drugs. With respect 
to, NCI and depression among our sample, there seems to have a very limited impact on the 
individual’s confidence regarding treatment adherence which might be related to potential 
correlation of the similar items constructs used in the assessment. Thus, study findings could be 
helpful in future work in developing efficacious intervention considering the potential influences 
that might benefits high risk people with cognitive impairment. 
Future direction includes exploring intervention strategies that involves greater use of the 
internet on the PrEP adherence and HIV risk reduction. The results suggest the importance of 
exploring the various intervention components in order to examine behavioral changes related to 
HIV and warrants further modeling using bidirectional approach to examine the impact among 
adherence self-efficacy-related variables. Based on our data, it seems that effective use of the 
internet or technological devices could be used to strengthen the patient and providers relationship 
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as well as enhancing HIV prevention outcomes. Likewise, future research should concentrate on 
how best to translate interest in PrEP information and motivation in the form of effective real-
world PrEP related interventions for optimal individual and community health. 
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APPENDIX 
Figure 3 - Histogram with normality plot of dependent variable 
 
Figure 4 - Q_Q plot of dependent variable(PrEP adherence self-efficacy) 
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      Figure 5 - Scatterplot to test for Homoscedasticity 
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Figure 6 - Histogram of residuals of motivation factor on dependent variable (PrEP 
adherence self-efficacy) 
 
Figure 7 Histogram of residuals of Internet use on dependent variable (PrEP adherence 
self-efficacy 
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Figure 8 P-P plot of the residuals 
                       
 
 
 
Table 8 Exploratory factor analysis of domains of Motivation related to PrEP 
Constructs Items Factor loadings 
Attitude 
towards 
PrEP 
If I were on PrEP, I’m sure that PrEP would be effective 
in protecting me from HIV-infection 
0.54 
I think I would be less worried about HIV infection if I 
were on PrEP. 
0.63 
If I were on PrEP, it would take the worry out of the sex. 0.65 
Intention 
motivation 
If I were on PrEP, I won’t have to worry about using 
condoms. 
0.78 
If I were on PrEP, I won’t have to worry about sharing 
needles and works. 
0.88 
If I were on PrEP, I won’t have to worry about my 
partner’s HIV status. 
0.77 
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Social 
motivation 
I would take PrEP if I know someone (for example, 
friend, and family member) who is currently taking it. 
0.53 
I have a responsibility to contribute to HIV prevention 
efforts by using PrEP. 
0.65 
I have family members or friends to encourage me to 
take PrEP properly. 
0.55 
If I disclose that I'm on PrEP to my sex partner, he or she 
will be comfortable with it. 
0.57 
 
   
 
 
        Table 9 Confirmatory factor analysis fit model of domains of motivation related to PrEP 
Number of observations                           400 
 
  Estimator                                                   ML 
  Minimum Function Test Statistic             105.81 
  Degrees of freedom                                   38 
  P-value (Chi-square)                                 0.00 
Model test baseline model: 
Minimum Function Test Statistic               1223.27 
 Degrees of freedom                                    55 
 P-value                                                       0.00 
 
 User model versus baseline model: 
 
Comparative Fit Index (CFI)                     0.94 
Tucker-Lewis Index (TLI)                         0.91 
 
Root Mean Square Error of Approximation: 
  
 RMSEA                                               0.067 
 90 Percent Confidence Interval           0.05   0.08 
 P-value RMSEA <= 0.05                    0.033 
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R code Exploratory and confirmatory factor analysis on R lavaan. 
Dataset “abc” is used to conduct factor analysis 
Primary component analysis: 
To obtain the data in r software from the data set. 
>home <- read.csv("~/Fall mediation project/home.csv") 
To install the R lavaan package from library. 
>library(lavaan) 
For primary/ Principal component Analyses. 
>surveya.pca<-princomp(abc) 
>summary(surveya.pca) 
 
R code for exploratory factor analysis. 
> surveybt<-factanal(abc, factor=4, rotation= "varimax") 
>library(lavaan) 
> surveybt 
 
R code for Confirmatory factor analysis: 
cfa.mod<-'intd=~prepm9+prepm10+prepm11 
 
+ somt=~prepm13+prepm14+prepm15 
 
+ values=~prepm3+prepm4+prepm5 
 
+ barriers=~prepm7+prepm8' 
 
> fitcf<-cfa(cfa.mod, data=abc) 
 
> summary(fitcf,fit.measures=TRUE) 
 
